These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

142 related items for PubMed ID: 17001998

  • 1. Sampling for international normalized ratios in patients on hemodialysis with central venous catheters.
    Boyd A, Dunne A, Townsend K, Pai AB.
    Nephrol Nurs J; 2006; 33(4):408-11. PubMed ID: 17001998
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. Statistical analysis for article: comparison of sampling methods for obtaining accurate coagulation values in hemodialysis patients with heparinized central venous catheters.
    Thomas-Hawkins C, Welch JL.
    Nephrol Nurs J; 2002 Apr; 29(2):109; author reply 109, 194. PubMed ID: 11997948
    [No Abstract] [Full Text] [Related]

  • 4. Inadvertent postdialysis anticoagulation due to heparin line locks.
    Pepper RJ, Gale DP, Wajed J, Bommayya G, Ashby D, McLean A, Laffan M, Maxwell PH.
    Hemodial Int; 2007 Oct; 11(4):430-4. PubMed ID: 17922740
    [Abstract] [Full Text] [Related]

  • 5. Measurement of the international normalized ratio (INR) in hemodialysis patients with heparin-locked central venous catheters: evaluation of a novel blood sampling method.
    Rioux JP, De Bortoli B, Quérin S, Déziel C, Troyanov S, Madore F.
    J Vasc Access; 2009 Oct; 10(3):180-2. PubMed ID: 19670171
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. [The impact of heparin bolus from dysfunctional lumen of dual lumen central venous catheter on activated partial thromboplastin time during hemodialysis: is additional heparinization necessary?].
    Sefer S, Kes P, Raić B, Heinrich B, Degoricija V, Szavits-Nossan J.
    Acta Med Croatica; 2006 Jun; 60(3):281-5. PubMed ID: 16933844
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. A comparison of coagulation study results between heparinized peripherally inserted central catheters and venipunctures.
    Humphries L, Baldwin KM, Clark KL, Tenuta V, Brumley K.
    Clin Nurse Spec; 2012 Jun; 26(6):310-6. PubMed ID: 23059715
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Concentration of heparin-locking solution and risk of central venous hemodialysis catheter malfunction.
    Thomas CM, Zhang J, Lim TH, Scott-Douglas N, Hons RB, Hemmelgarn BR, Alberta Kidney Disease Network.
    ASAIO J; 2007 Jun; 53(4):485-8. PubMed ID: 17667236
    [Abstract] [Full Text] [Related]

  • 12. A randomized, controlled trial of heparin versus placebo infusion to prolong the usability of peripherally placed percutaneous central venous catheters (PCVCs) in neonates: the HIP (Heparin Infusion for PCVC) study.
    Shah PS, Kalyn A, Satodia P, Dunn MS, Parvez B, Daneman A, Salem S, Glanc P, Ohlsson A, Shah V.
    Pediatrics; 2007 Jan; 119(1):e284-91. PubMed ID: 17200252
    [Abstract] [Full Text] [Related]

  • 13. Accuracy of coagulation values obtained from a heparinized central venous catheter.
    Pinto KM.
    Oncol Nurs Forum; 1994 Apr; 21(3):573-5. PubMed ID: 8052553
    [Abstract] [Full Text] [Related]

  • 14. [Comparative study between 20 IU/ml heparin and 5% heparin/urokinase 5000 IU lock in hemodialysis central venous catheters with permeability problems].
    Pelayo Alonso R, Cobo Sánchez JL, de Buruaga Perea AS, Menezo Viadero R, Gándara Revuelta M, Aja Crespo A, Tovar Rincón A.
    Rev Enferm; 2013 Mar; 36(3):8-12. PubMed ID: 23654184
    [Abstract] [Full Text] [Related]

  • 15. The effect of sodium citrate 4% locking solution for central venous dialysis catheter on the international normalized ratio (INR) value.
    Rioux JP, De Bortoli B, Troyanov S, Madore F.
    Nephrol Dial Transplant; 2008 May; 23(5):1772-3; author reply 1773. PubMed ID: 18216181
    [No Abstract] [Full Text] [Related]

  • 16. Time to hemostasis after traction removal of tunneled cuffed central venous catheters.
    Stecker MS, Johnson MS, Ying J, McLennan G, Agarwal DM, Namyslowski J, Ahmad I, Shah H, Butty S, Casciani T.
    J Vasc Interv Radiol; 2007 Oct; 18(10):1232-9; quiz 1240. PubMed ID: 17911513
    [Abstract] [Full Text] [Related]

  • 17. Systemic anticoagulant prophylaxis for central catheter-associated venous thrombosis in cancer patients.
    Chan A, Iannucci A, Dager WE.
    Ann Pharmacother; 2007 Apr; 41(4):635-41. PubMed ID: 17355999
    [Abstract] [Full Text] [Related]

  • 18. Prospective study of peripheral arterial catheter infection and comparison with concurrently sited central venous catheters.
    Koh DB, Gowardman JR, Rickard CM, Robertson IK, Brown A.
    Crit Care Med; 2008 Feb; 36(2):397-402. PubMed ID: 18216598
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Minimum discard volume from arterial catheters to obtain coagulation studies free of heparin effect.
    Reinhardt AC, Tonneson AS, Bracey A, Goodnough SK.
    Heart Lung; 1987 Nov; 16(6 Pt 1):699-705. PubMed ID: 3679864
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.